Abstract
BackgroundThe merozoite surface protein (MSP)-1 is a target antigen of protective immunity and a malaria vaccine candidate. The nature of this protective immune response warrants further investigation: although specific antibody is thought to play a major role, the mechanisms of protection are still unclear. Monoclonal antibodies (mAbs) specific for the C-terminus of MSP-1 from Plasmodium yoelii have been shown previously to provide protection against challenge infection when administered by passive immunization to mice. Three protective mAbs were re-examined and, in particular, the effect of combinations of antibodies on the protection provided was studied. It was found that a combination of two antibodies can either provide additive protective effects or result in a suppression of protection. In this report the importance of antibody subclass and epitope specificity in the outcome of these passive immunization experiments are discussed.MethodsThe minimum protective dose (MPD) for each mAb was determined, and then combinations of antibody at their MPD were investigated for their ability to control parasitaemia and promote survival in groups of mice. Mice were inoculated over three days with the MPD and challenged with a blood stage infection of the virulent P. yoelii 17 XL. The resultant parasitaemia was assessed daily on Giemsa-stained blood films. Following the infection the presence of MSP-1 specific antibodies in the sera was monitored, and the proliferative responses of cells in the spleen of protected mice were measured.ResultsCombining antibodies resulted in either an additive effect on protection, with reduced peak parasitaemia and better survival, or resulted in a suppression of protection over that achieved by a single antibody alone. An additive effect was observed when B6 and F5 that have the same isotype and similar fine specificity, were combined. However, a combination of mAb D3, an IgG2a, with either B6 or F5 (both IgG3) suppressed protection, an effect that may have been due to the combination of different isotypes or to the different fine specificity of the antibodies.ConclusionsThese results suggest that a combination of protective antibodies with either the same or different isotypes can produce either an additive or a suppressive effect in passive immunization. This phenomenon may be important in better understanding immunity in this experimental mouse model of malaria.
Highlights
The merozoite surface protein (MSP)-1 is a target antigen of protective immunity and a malaria vaccine candidate
At invasion this fragment is further cleaved into two further fragments, one of which is the C-terminal 19 kDa fragment (MSP-119) that is comprised of two epidermal growth factor-like domains and remains on the surface of the parasite through erythrocyte invasion
The ability of three monoclonal antibodies specific for the merozoite surface protein MSP-1 to provide protection against infection with the rodent malaria parasite P. yoelii by passive immunization was investigated
Summary
The merozoite surface protein (MSP)-1 is a target antigen of protective immunity and a malaria vaccine candidate. There is abundant evidence to suggest that the C-terminal region of this molecule, represented by a 42 kDa fragment on the merozoite surface (MSP142), is the target of antibodies that are important in protective immunity [4]. At invasion this fragment is further cleaved into two further fragments, one of which is the C-terminal 19 kDa fragment (MSP-119) that is comprised of two epidermal growth factor-like domains and remains on the surface of the parasite through erythrocyte invasion
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
